Neural stem cell therapy (Stemedica Cell Technologies)

N/A

Report date: 2025/04/09 16:31:46

Base Information

Drug NameNeural stem cell therapy (Stemedica Cell Technologies)
Drug Alias NameIschaemia-tolerant neural stem cellsStemedyne-NSCitNSC
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Neural stem cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsDiabetic RetinopathySpinal Cord InjuriesAlzheimer Disease +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesStemedica Cell Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStemedica Cell Technologies Inc
Active IndicationsN/A
Inactive IndicationsDiabetic RetinopathySpinal Cord InjuriesAlzheimer Disease +[5] 

Other Information

ATC CodeN/A
Related LinksN/A